Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS. The study provides evidence that lays a foundation for developing future gene replacement therapies to treat patients with the fatal neuromuscular disorder.